CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-18 | Morris Clive President of Inivata | Grant or award · Stock Option (Right to Buy) | +53,857 | $43.58 | $2.3M | 53,857 |
| 2021-06-11 | TETRAULT LYNN A. Director | Exercise or conversion | +1,389 | $9.11 | $13K | 34,939 |
| 2021-06-11 | TETRAULT LYNN A. Director | Exercise or conversion · Stock Option (Right to Buy) | −1,389 | 0 | ||
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion | +10,000 | $7.27 | $73K | 59,564 |
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion | +3,017 | $11.60 | $35K | 62,581 |
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion | +4,269 | $22.52 | $96K | 66,850 |
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion | +3,448 | $28.54 | $98K | 70,298 |
| 2021-06-08 | CROWTHER BRUCE K Director | Sale | −20,734 | $41.46 | $860K | 49,564 |
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion · Stock Option (Right to Buy) | −3,017 | 0 | ||
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion · Stock Option (Right to Buy) | −4,269 | 0 | ||
| 2021-06-08 | CROWTHER BRUCE K Director | Exercise or conversion · Stock Option (Right to Buy) | −3,448 | 0 | ||
| 2021-06-03 | CARDOZA GEORGE President, Pharma Services | Sale | −31,107 | $40.11 | $1.2M | 176,772 |
| 2021-06-02 | HANNAH ALISON L. Director | Grant or award | +3,081 | 91,877 | ||
| 2021-06-02 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | Kelly Michael Aaron Director | Grant or award | +3,081 | 4,863 | ||
| 2021-06-02 | Kelly Michael Aaron Director | Grant or award · Stock Option (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | Johnson Kevin C Director | Grant or award | +3,081 | 34,064 | ||
| 2021-06-02 | Johnson Kevin C Director | Grant or award · Stock Options (Right to Buy) | +3,714 | 3,714 | ||
| 2021-06-02 | Stahler Rachel A Director | Grant or award | +3,081 | 5,779 |
Page 24 of 51 · 1,005 trades